Home/Orcapedia/Do continuous glucose monitors help healthy people?
Possibly. The evidence is mixed, emerging or strongly context-dependent.
Possibly. The evidence is mixed, emerging or strongly context-dependent. There may be a real effect for some people, but it is usually smaller and more specific than the marketing suggests.
Continuous glucose monitors were developed and FDA-approved specifically for people with diabetes to manage insulin dosing; it was only in 2024 that the FDA cleared the first over-the-counter CGMs (such as Dexcom Stelo and Abbott Lingo) intended for use by people without diabetes, marking a genuinely new regulatory category rather than an established wellness tool.
A small adhesive sensor worn on the arm or abdomen that measures glucose in interstitial fluid every few minutes and streams the data to a phone app, originally developed for people with diabetes to avoid repeated finger-prick testing.
Consumer versions marketed to non-diabetics promise real-time feedback on how specific foods, exercise or stress affect blood sugar, tapping into biohacking and quantified-self culture. Popularity grew through fitness influencers and metabolic-health startups framing glucose spikes as a hidden driver of energy crashes, cravings and long-term weight gain.
Possibly. The evidence is mixed, emerging or strongly context-dependent. There may be a real effect for some people, but it is usually smaller and more specific than the marketing suggests.
Relevant mechanisms: what the device actually measures or delivers, signal quality, calibration, algorithms, user behaviour and expectation.
The mechanism has been photographed beautifully. The evidence would still like to see the spreadsheet.
People often start a new intervention when a symptom is unusually bad. Many fluctuating symptoms naturally move back toward their usual level. If a new product was started at the low point, ordinary improvement can look like a treatment effect — the timeline is simply flattering the newest object in the bathroom.
Once someone has invested money, attention and hope, the mind naturally notices confirming evidence. Good day after starting: it worked. Bad day: probably needs another week. No change: maybe the dose is wrong. This is why predefined outcomes and stop rules matter — they protect the experiment from becoming a subscription.
Expectation, attention, previous experience, ritual, sensory cues and other simultaneous behaviour changes can all influence subjective outcomes such as pain, sleep quality, stress, energy and mood. Subjective improvement alone can't tell us which mechanism caused it — that's what a comparison group is for.
Consumer devices can misclassify data and should not overrule symptoms or clinician-grade testing. Check contraindications for electrical, magnetic or heat-based devices.
If you want an honest cue for this behaviour rather than a medical claim, OrcaBrain is built for exactly that job — a placebo, not a treatment.
Do continuous glucose monitors help healthy people? Possibly. The evidence is mixed, emerging or strongly context-dependent. There may be a real effect for some people, but it is usually smaller and more specific than the marketing suggests.
Can this replace medical treatment? No. A wellness ritual can complement appropriate care, but it should not replace diagnosis, prescribed treatment or urgent assessment.
“Compared with what, for which outcome, by how much, for how long, and at what risk?”